Novo Nordisk
Big pharma CEOs announce net zero action plan
November 03 by Leila HawkinsSeven major pharma companies join forces to tackle the sector’s greenhouse gas emissions
Top 10 pharma execs leading sustainability efforts
June 09 by Leila HawkinsPharma IQ lists 10 pharma execs leading efforts to drive sustainability goals
The need for equipment integration in quality control labs
January 28 by Michael JustesenMichael Justesen, IT & Automation Strategy Specialist at Novo Nordisk, is speaking at Pharma IQ’s SmartLab Digital event in March. Ahead of his session, Justesen explains the importance of standardiza...
Keeping tabs on pharma: Novo Nordisk’s diabetes "game-changer" and the rise of antibiotic resistance
January 21 by Leila HawkinsIn Pharma IQ’s latest news bulletin: Novo Nordisk India’s ground-breaking diabetes pill, the threat of antibiotic resistance and a new nasal drug that could combat Covid-19
Top 10 of who is recruiting in pharma
July 11 by Pharma IQDespite some in the market choosing to shut down certain departments, many in the pharma industry are embarking on expansions. Ireland is expected to see a lot of growth
7 Predictions for Pharma
January 06 by Andrea CharlesThe following predictions were based on interviews with range of professionals in the pharma and biotech space. To hear from these thought leaders and more go to the Pharma Show Podca...
Top 3 Best Practices for Complying with the Development Safety Update Report (DSUR)
January 06 by Andrea CharlesPilar Carrero, Director of Safety Medical Writing at Novo Nordisk, joined Pharma IQ to discuss the impact social media has had on drug safety and risk management and the dawn of a new era for p...
Message from the Regulators: Pharmacovigilance to Move Heavily into Risk-Benefit Assessment
November 25 by Pharma IQPilar Carrero Director of Safety Medical Writing at Novo Nordisk, joins Andrea Charles from Pharma IQ, to discuss the impact social media has had on drug safety and risk managment and the dawn...
Novo Nordisk's Søren Skovlund Speaks to Pharma IQ about Best Practice Approaches to Patient Education and Self-Management
April 19 by Soren SkovlundSøren Skovlund is director of global patient research, advocacy and support in Novo Nordisk and oversees the global DAWN (Diabetes Attitudes Wishes & Needs) study led by Novo Nordisk. In...